Alexa Desilva
Family Medicine · Rancho Santa Margarita, CANPI 1023630753
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 198 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AstraZeneca at 29.9% of the total. Among family medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 198 payments — averaging $28.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- AbbVie$984
- Lilly USA, LLC$521
- GSK$509
- Amgen$433
- Pfizer$198
- plus $1K from 23 others
What the payments were for
- Food & beverage$5,696100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 49 | $1,705 |
| AbbVie | 30 | $984 |
| Lilly USA, LLC | 17 | $521 |
| GSK | 20 | $509 |
| Amgen | 12 | $433 |
| Pfizer | 9 | $198 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $183 |
| Merck | 8 | $154 |
| Kowa Pharmaceuticals America, Inc. | 7 | $150 |
| Novo Nordisk | 5 | $125 |
| Exact Sciences | 4 | $107 |
| Eisai Inc. | 5 | $91 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $76 |
| Johnson & Johnson | 3 | $74 |
| Lucid Diagnostics Inc. | 2 | $40 |
| Sanofi Pasteur Inc. | 1 | $36 |
| Tolmar, Inc. | 1 | $33 |
| Hologic Sales And Service, LLC | 2 | $30 |
| Ironwood Pharmaceuticals, Inc | 1 | $30 |
| Edwards Lifesciences | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Amarin Pharma, Inc. | 1 | $25 |
| Agile Therapeutics, Inc. | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| IBSA Pharma Inc. | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Therapeuticsmd, Inc. | 1 | $17 |
| Icad, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,696 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 79 | $858 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 22 | $559 |
| Levothyroxine Sodium | 30 | $324 |
| Rosuvastatin Calcium | 28 | $313 |
| Meloxicam | 23 | $291 |
| Escitalopram Oxalate | 20 | $265 |
| Losartan Potassium | 31 | $185 |
| Gabapentin | 11 | $182 |
| Simvastatin | 16 | $173 |
| Metformin Hcl ErMetformin Hcl | 22 | $134 |
| Lisinopril | 16 | $119 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 22 | $99 |
| Alprazolam | 17 | $29 |
| Azithromycin | 14 | $25 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Rancho Santa Margarita
- Sherly SoleimanEncino$1.2M
- Pamela KushnerLos Angeles$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Sandra CalmanMontara$589K
- Anthony JonesOakland$377K
- Amira AyadBakersfield$360K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.